China National Medical Products Administration Approves MR-guided Focused Ultrasound To Treat Essential Tremor And Tremor-dominant Parkinson’s Disease

Insightec is strategically positioned for expansion in the China market Insightec®, a global healthcare company focused on creating the next generation of patient care, announced it received market approval by The National Medical Products Administration (NMPA), the Chinese agency for regulating drugs and medical devices (formerly the China Food and Drug Administration, or CFDA). The […]

10 ก.พ. 64

Orpha Labs AG Initiates Compassionate Use Program for ORL-101 in Leukocyte Adhesion Deficiency Type II (LAD-II)

First Patient to Receive ORL-101 in Israel This Week Orpha Labs AG today announced its compassionate use program to make ORL–101 available to physicians providing care for Leukocyte Adhesion Deficiency Type II (LAD-II) patients. ORL-101 is a novel formulation of an ultra-pure L-fucose currently in development for the treatment of LAD II patients. The Israeli […]

8 ก.พ. 64

TCAI physicians participate in clinical trial for potential life-saving device for patients with heart rhythm disorders

Physicians with the Texas Cardiac Arrhythmia Institute (TCAI) at St. David’s Medical Center are among the first in the world to participate in a clinical trial to evaluate a new esophageal protection device designed to make ablation procedures safer for patients with atrial fibrillation (A Fib), the most common type of cardiac arrhythmia. Andrea Natale, M.D., F.H.R.S., F.A.C.C., […]

5 ก.พ. 64

Global survey presented at the Digital Liver Cancer Summit 2021 reveals heavy toll of COVID-19 first wave on liver cancer care

Digital Liver Cancer Summit 2021: A global survey assessing the impact of COVID-19 on liver cancer has revealed delays in the screening, diagnosis, and treatment of the disease, with experts issuing stark warnings on liver cancer survival rates. The delays of screening programmes, diagnostic imaging and biopsies, cuts in the numbers of physicians available to […]

5 ก.พ. 64

Phase 1 Drug Candidate GLR2007 Developed by Gan & Lee has been Granted Fast Track Designation by the U.S. FDA

Gan & Lee Pharmaceuticals Co., Ltd. (hereinafter referred to as Gan & Lee) (Shanghai: 603087.SH), a global biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for GLR2007, for the treatment of patients with glioblastoma. GLR2007 is a cyclin-dependent kinase 4/6 (CDK 4/6) inhibitor that Gan & Lee […]

5 ก.พ. 64

NCCN Gets Personal About Improving Global Cancer Care for World Cancer Day

Nonprofit alliance behind gold standard oncology guidelines shares stories of personal connections to cancer that inspire many within the organization. Global oncology community looks at the impact from COVID-19 on cancer care over the past year. The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers in the United States—joins people and organizations worldwide in commemorating World Cancer […]

4 ก.พ. 64

Mindray Launches New BeneFusion e Series Infusion Systems, Delivering Efficiency in Every Droplet

Mindray (SZSE: 300760), a global leader in the development of innovative healthcare technology, has unveiled its BeneFusion e Series, a revolutionary efficient infusion system for the healthcare industry. Available in three models, eSP, eVP and eDS, the BeneFusion e Series delivers efficiency in workflow, safety, application and informatics. This brand-new series will be available in […]

3 ก.พ. 64

Globally unique MRI Guarantee: The highest MRI safety with hearing implants from MED-EL

Worry-free, safe magnetic resonance imaging (MRI) with MED-EL cochlear, middle ear or bone conduction implants – now with lifetime guarantee. For immediate access to an MRI examination without surgery, discomfort or hearing downtime. The innovative design of the implant magnets from MED-EL is completely safe during an MRI examination. As of now, the global innovation […]

2 ก.พ. 64
1 68 69 70 71 72 77